Mylan prepares hydroxychloroquine giveaways after production ramp-up
Mylan is one of a group of drugmakers that have joined the global effort to supply doses of generic hydroxychloroquine, an antimalarial touted as a possible COVID-19 therapy, to ongoing clinical trials. Now, after ramping up production, Mylan is ready to dole out its stockpile faster than expected. After announcing last month it would restart… Read More »
